tiprankstipranks
Advertisement
Advertisement

AMLX Stock Latest News

Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential
RatingsBuy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential
6d ago
AMLX
Amylyx Highlights Pipeline Progress in Updated Corporate Presentation
PremiumCompany Announcements
Amylyx Highlights Pipeline Progress in Updated Corporate Presentation
21d ago
8K
AMLX
Amylyx completes enrollment in Phase 3 Lucidity trial of avexitide
PremiumThe Fly
Amylyx completes enrollment in Phase 3 Lucidity trial of avexitide
21d ago
AMLX
Amylyx price target raised to $30 from $25 at Guggenheim
PremiumThe Fly
Amylyx price target raised to $30 from $25 at Guggenheim
26d ago
AMLX
Buy Rating on Amylyx Pharmaceuticals Driven by Avexitide’s Commercial Potential and De-Risked Phase III PBH Program
PremiumRatings
Buy Rating on Amylyx Pharmaceuticals Driven by Avexitide’s Commercial Potential and De-Risked Phase III PBH Program
29d ago
AMLX
Amylyx Pharmaceuticals Maps High-Stakes Path to 2027
PremiumCompany AnnouncementsAmylyx Pharmaceuticals Maps High-Stakes Path to 2027
1M ago
AMLX
Amylyx price target raised to $34 from $28 at H.C. Wainwright
Premium
The Fly
Amylyx price target raised to $34 from $28 at H.C. Wainwright
1M ago
AMLX
Amylyx Pharmaceuticals: Solid Balance Sheet, Advancing Pipeline, and Attractive Risk‑Reward Support Buy Rating
Premium
Ratings
Amylyx Pharmaceuticals: Solid Balance Sheet, Advancing Pipeline, and Attractive Risk‑Reward Support Buy Rating
1M ago
AMLX
Amylyx files automatic mixed securities shelf
PremiumThe Fly
Amylyx files automatic mixed securities shelf
1M ago
AMLX
Amylyx reports Q4 EPS (30c), consensus (34c)
PremiumThe Fly
Amylyx reports Q4 EPS (30c), consensus (34c)
1M ago
AMLX
Amylyx initiated with a Buy at Stifel
PremiumThe Fly
Amylyx initiated with a Buy at Stifel
1M ago
AMLX
Is AMLX a Buy, Before Earnings?
PremiumPre-Earnings
Is AMLX a Buy, Before Earnings?
1M ago
AMLX
Amylyx price target raised to $19 from $15 at BofA
PremiumThe FlyAmylyx price target raised to $19 from $15 at BofA
2M ago
AMLX
Amylyx price target raised to $19 from $18 at Mizuho
Premium
The Fly
Amylyx price target raised to $19 from $18 at Mizuho
2M ago
AMLX
Amylyx price target raised to $19 from $18 at Mizuho
Premium
The Fly
Amylyx price target raised to $19 from $18 at Mizuho
2M ago
AMLX
Amylyx price target raised to $28 from $20 at H.C. Wainwright
PremiumThe Fly
Amylyx price target raised to $28 from $20 at H.C. Wainwright
2M ago
AMLX
Buy Rating on Amylyx: Avexitide’s High Unmet Need, Strong PBH Opportunity, and Clear Phase III Catalyst Support Upside
PremiumRatings
Buy Rating on Amylyx: Avexitide’s High Unmet Need, Strong PBH Opportunity, and Clear Phase III Catalyst Support Upside
3M ago
AMLX
Amylyx Advances AMX0318 as New Rare-Disease Candidate
PremiumCompany Announcements
Amylyx Advances AMX0318 as New Rare-Disease Candidate
3M ago
8K
AMLX
Amylyx selects AMX0318 as development candidate for PBH
PremiumThe Fly
Amylyx selects AMX0318 as development candidate for PBH
3M ago
AMLX
Amylyx price target lowered to $15 from $16 at BofA
PremiumThe FlyAmylyx price target lowered to $15 from $16 at BofA
4M ago
AMLX
Positive Buy Rating for Amylyx Pharmaceuticals Based on Promising Phase I LUMINA Study Results and Strategic Advancements
Premium
Ratings
Positive Buy Rating for Amylyx Pharmaceuticals Based on Promising Phase I LUMINA Study Results and Strategic Advancements
4M ago
AMLX
Amylyx price target raised to $18 from $16 at Mizuho
Premium
The Fly
Amylyx price target raised to $18 from $16 at Mizuho
5M ago
AMLX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >